#news #biotech GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO .GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO
badams
Wed, 05/26/2021 – 03:58

from FierceBiotech: Biotech https://ift.tt/2RNFGqr